SARATOGA INVESTMENT CORP. current report, 05 December 2022

Saratoga Investment Corp. 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Saratoga Investment Corp. on December 6, 2022, reporting events occurring on December 5, 2022. The Company is a Maryland corporation with principal executive offices in New York, New York. It is listed on the New York Stock Exchange under the symbols SAR (Common Stock), SAT (6.00% Notes due 2027), and SAJ (8.00% Notes due 2027).

Key Financial Metrics and Transaction Details

The filing details a new debt offering rather than periodic financial performance metrics. Key transaction figures include:

  • Primary Offering Amount: $52,500,000 aggregate principal amount of 8.125% Notes due 2027.
  • Over-Allotment Option: Underwriters may purchase up to an additional $7,875,000 of Notes within 30 days.
  • Expected Closing Date: December 13, 2022.
  • Trading Symbol: The new Notes are expected to trade under the symbol "SAY" on the NYSE.

The filing text does not provide specific values for revenue, profit, cash flow, margins, or existing debt levels as this is a transactional report.

Material Changes

The primary material change is the entry into a definitive underwriting agreement to issue new senior notes. This creates a direct financial obligation for the Company. The transaction is being executed pursuant to an effective shelf registration statement on Form N-2 (File No. 333-256366).

Outlook, Risks, and Management Commentary

The Company intends to list the new Notes on the New York Stock Exchange within 30 days of the original issue date. The Underwriting Agreement includes customary representations, warranties, covenants, and indemnification provisions. The filing explicitly states it does not constitute an offer to sell securities in jurisdictions where such an offer would be unlawful prior to registration.

Investor Verification Checklist

  • Verify the final closing of the $52.5 million offering on or around December 13, 2022.
  • Confirm whether the underwriters exercised the $7,875,000 over-allotment option.
  • Review the full text of the Underwriting Agreement (Exhibit 1.1) for specific covenants and use of proceeds.
  • Monitor the listing of the new Notes under the symbol "SAY" on the NYSE.
  • Check subsequent filings for the impact of this new debt on the Company's leverage ratios and liquidity position.